Dr Koen Ameloot (Universitair Ziekenhuis Leuven, BE) discusses the Neuroprotect trial - Early goal-directed hemodynamic optimization in comatose survivors after out-of-hospital cardiac arrest.
Filmed by Radcliffe Cardiology on site at AHA 2018.
Video
Published: 21 Nov 2018
Views:
86Likes:
0
Dr Koen Ameloot (Universitair Ziekenhuis Leuven, BE) discusses the Neuroprotect trial - Early goal-directed hemodynamic optimization in comatose survivors after out-of-hospital cardiac arrest.
Filmed by Radcliffe Cardiology on site at AHA 2018.